African-Americans living with HIV show worse health behaviors (e.g. medication adherence) and outcomes (e.g. viral suppression) than do their White counterparts. In a 6-month longitudinal study, we investigated whether medical mistrust among African-American males with HIV (214 enrolled, 140 with longitudinal data) predicted lower electronically monitored antiretroviral medication adherence. General medical mistrust (e.g. suspicion toward providers), but not racism-related mistrust (e.g. belief that providers treat African-Americans poorly due to race), predicted lower continuous medication adherence over time (b = −.08, standard error = .04, p = .03). Medical mistrust may contribute to poor health outcomes. Intervention efforts that address mistrust may improve adherence among African-Americans with HIV.
ArmstrongKMcMurphySDeanLT. (2008) Differences in the patterns of health care system distrust between blacks and whites. Journal of General Internal Medicine23: 827–833.
2.
ArmstrongKRavenellKLMcMurphyS. (2007) Racial/ethnic differences in physician distrust in the United States. American Journal of Public Health97: 1283–1289.
3.
ArnstenJHDemasPAGrantRW. (2002) Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine17: 377–381.
4.
BangsbergDHechtFCharleboisE. (2001) Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior5: 275–281.
5.
BangsbergDR (2006) Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases43: 939–941.
6.
BogartLMLandrineHGalvanFH. (2013) Perceived discrimination and physical health among HIV-positive Black and Latino men who have sex with men. AIDS and Behavior17: 1431–1441.
7.
BogartLMWagnerGGalvanFH. (2010a) Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. Journal of Acquired Immune Deficiency Syndromes53: 648–655.
8.
BogartLMWagnerGJGalvanFH. (2010b) Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Annals of Behavioral Medicine40: 184–190.
9.
BurnettMGenaoIWongWF (2005) Race, culture, and trust: Why should I take a shot if I’m not sick?Ethnicity & Disease15: S3-13–S3-16.
DavisJLBynumSAKatzRV. (2012) Sociodemographic differences in fears and mistrust contributing to unwillingness to participate in cancer screenings. Journal of Health Care for the Poor and Underserved23: 67–76.
12.
GambleVN (1997) Under the shadow of Tuskegee: African Americans and health care. American Journal of Public Health87: 1773–1778.
13.
GastonGB (2013) African-Americans’ perceptions of health care provider cultural competence that promote HIV medical self-care and antiretroviral medication adherence. AIDS Care25: 1159–1165.
14.
GastonGBAlleyne-GreenB (2013) The impact of African Americans’ beliefs about HIV medical care on treatment adherence: a systematic review and recommendations for interventions. AIDS and Behavior17: 31–40.
15.
GolinCELiuHHaysRD. (2002) A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine17: 756–765.
16.
GulickRM (2006) Adherence to antiretroviral therapy: How much is enough?Clinical Infectious Diseases43: 942–944.
17.
HammondWPMatthewsDCorbie-SmithG (2010a) Psychosocial factors associated with routine health examination scheduling and receipt among African American men. Journal of the National Medical Association102: 276–289.
18.
HammondWPMatthewsDMohottigeD. (2010b) Masculinity, medical mistrust, and preventive health services delays among community-dwelling African-American men. Journal of General Internal Medicine25: 1300–1308.
19.
HausmannLRKressinNRHanusaBH. (2010) Perceived racial discrimination in health care and its association with patients’ healthcare experiences: Does the measure matter?Ethnicity & Disease20: 40–47.
20.
HausmannLRKwohCKHannonMJ. (2013) Perceived racial discrimination in health care and race differences in physician trust. Race and Social Problems5: 113–120.
21.
KageeASwartzASwartzL (2014) Theorising beyond the individual: Adherence to antiretroviral therapy in resource-constrained societies. Journal of Health Psychology19: 103–109.
22.
KalichmanSCPopeHWhiteD. (2008) Association between health literacy and HIV treatment adherence: Further evidence from objectively measured medication adherence. Journal of the International Association of Physicians in AIDS Care (Chic)7: 317–323.
23.
KobinABShethNU (2011) Levels of adherence required for virologic suppression among newer antiretroviral medications. Annals of Pharmacotherapy45: 372–379.
24.
LaVeistTANickersonKJBowieJV (2000) Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Medical Care Research and Review57(Suppl. 1): 146–161.
25.
LinnAJvan WeertJCvan DijkL. (2014) The value of nurses’ tailored communication when discussing medicines: Exploring the relationship between satisfaction, beliefs and adherence. Journal of Health Psychology. Epub ahead of print 4July. DOI:10.1177/1359105314539529.
26.
McNabbJRossJWAbriolaK. (2001) Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clinical Infectious Diseases33: 700–705.
27.
MadoreSKilbournKValverdeP. (2014) Feasibility of a psychosocial and patient navigation intervention to improve access to treatment among underserved breast cancer patients. Support Care in Cancer22: 2085–2093.
28.
MugaveroMJLinHYAllisonJJ. (2009) Racial disparities in HIV virologic failure: Do missed visits matter?Journal of Acquired Immune Deficiency Syndromes50: 100–108.
29.
MullerADMyerLJaspanH (2009) Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy. Clinical Infectious Diseases48: e3–e5.
30.
NeacsiuADEberleJWKramerR. (2014) Dialectical behavior therapy skills for transdiagnostic emotion dysregulation: A pilot randomized controlled trial. Behaviour Research and Therapy59C: 40–51.
31.
OlemDSharpKMTaylorJM. (2014) Overcoming barriers to HIV treatment adherence: A brief cognitive behavioral intervention for HIV-positive adults on antiretroviral treatment. Cognitive and Behavioral Practice21: 206–223.
32.
SafrenSAO’CleirighCMBullisJR. (2012) Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology80: 404–415.
33.
SheppardVBMaysDLaVeistT. (2013) Medical mistrust influences black women’s level of engagement in BRCA 1/2 genetic counseling and testing. Journal of the National Medical Association105: 17–22.
34.
ShuterJSarloJAKanmazTJ. (2007) HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. Journal of Acquired Immune Deficiency Syndromes45: 4–8.
35.
SilverbergMJLeydenWQuesenberryCPJr. (2009) Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. Journal of General Internal Medicine24: 1065–1072.
36.
SimoniJMHuhDWilsonIB. (2012) Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 study. Journal of Acquired Immune Deficiency Syndromes60: 466–472.
37.
ThrasherADEarpJAGolinCE. (2008) Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes49: 84–93.
38.
TullerDMBangsbergDRSenkunguJ. (2010) Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: A qualitative study. AIDS and Behavior14: 778–784.
